Scientists Determine Why Some Patients Don’t Respond Well to Wet Macular Degeneration Treatment, Show How New Experimental Drug Can Bridge Gap

A new study from researchers at Wilmer Eye Institute, Johns Hopkins Medicine explains not only why some patients with wet age-related macular degeneration (or “wet” AMD) fail to have vision improvement with treatment, but also how an experimental drug could be used with existing wet AMD treatments to save vision.